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a b s t r a c t
Smad proteins convey canonical intracellular signals for activated receptors in the TGFβ superfamily, but
the activity of Smads and their impact on target genes are further regulated by a wide variety of cofactors
and partner proteins. We have identiﬁed a new Smad1 partner, a GTPase named Gtpbp2 that is a distant
relative of the translation factor eEf1a. Gtpbp2 affects canonical signaling in the BMP branch of the TGFβ
superfamily, as morpholino knockdown of Gtpbp2 decreases, and overexpression of Gtpbp2 enhances,
animal cap responses to BMP4. During Xenopus development, gtpbp2 transcripts are maternally
expressed and localized to the egg animal pole, and partitioned into the nascent ectodermal and
mesodermal cells during cleavage and early gastrulation stages. Subsequently, gtpbp2 is expressed in the
neural folds, and in early tadpoles undergoing organogenesis gtpbp2 is expressed prominently in the
brain, eyes, somites, ventral blood island and branchial arches. Consistent with its expression,
morpholino knockdown of Gtpbp2 causes defects in ventral–posterior germ layer patterning, gastrula-
tion and tadpole morphology. Overexpressed Gtpbp2 can induce ventral–posterior marker genes and
localize to cell nuclei in Xenopus animal caps, highlighting its role in regulating BMP signaling in the
early embryo. Here, we introduce this large GTPase as a novel factor in BMP signaling and ventral–
posterior patterning.
& 2014 Elsevier Inc. All rights reserved.
Introduction
The Transforming Growth Factor β (TGFβ) superfamily regu-
lates a diverse set of biological processes, such as cell proliferation,
adhesion, migration, apoptosis, differentiation embryonic pattern
formation and organogenesis (ten Dijke et al., 2002; Shi and
Massagué, 2003; Feng and Derynck, 2005; Schier and Talbot,
2005). Ligands in the TGFβ superfamily bind to particular combi-
nations of serine/threonine kinase receptors that signal through
Smad and non-Smad-dependent pathways (Moustakas and
Heldin, 2005, 2012). In canonical mode, ligand-bound receptors
activate R-Smads to signal downstream to target genes. R-Smad
signaling is grouped into two distinct branches, with Smads1/5/8
conveying BMP/GDF signals and Smads2/3 operating under Acti-
vin/Nodal/TGFβ.
Genes encoding TGFβ signaling components, and many of their
functions, are well conserved throughout the metazoa, regulating
embryonic development in animals as diverse as ancient diploblast
lineages (cnidaria and ctenophora) through complex triploblasts
(chordata). In vertebrate embryos in particular, Nodal/Vg1 and
BMP-related pathways provide essential signals that induce and
pattern the primary germ layers, regulate tissue morphogenesis and
left–right asymmetry, and affect cellular pluripotency, differentia-
tion, growth and death. TGFβ signals often act in concert with FGF
and Wnt signaling in these developmental processes. In Xenopus
embryos in particular, mesoderm and endoderm are induced by
Nodals, Vg1 and Derriere ligands, acting together with FGFs, and
early tissue patterning is achieved by BMPs alongside Wnt and
FGF signals (Heasman, 2006; Kimelman, 2006; Itasaki and Hoppler,
2010). In the ectoderm, different levels BMP signaling triggers
differentiation of the epidermis, neural crest, sensory placodes
and neural tissues (DeRobertis and Kuroda, 2004; Vonica and
Brivanlou, 2006; Rogers et al., 2009).
Because of their importance in embryonic development and
tissue homeostasis, a variety of mechanisms have evolved to
regulate the activity of TGFβ pathways at all levels, from ligand
production and extracellular regulation, through receptors, signal
transducers and transcriptional cofactors (Itoh and ten Dijke,
2007). To explore regulation at the level of signal transduction,
we sought to identify new partners of BMP/Smad signaling by
performing yeast two-hybrid screens with Smad1 (Zhu et al.,
1999), which retrieved several TGFβ signaling regulators, including
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Smurf1 (Zhu et al., 1999; Thomsen, 2013), Eps15r (Callery et al.,
2012), and XMan (Osada et al., 2003; our unpublished results).
Another factor we retrieved is Gtpbp2, a large GTPase distantly
related to the translational regulators eEf1a1, Gspt1 (eRF3) and
Hbs1-like (Kudo et al., 2000). No function has been ascribed to
Gtpbp2, although it has shown to be expressed in developing
mouse embryos (Watanabe et al., 2000; Kudo et al., 2000). Gtpbp2
has a conserved yet distinct paralog, Gtpbp1, that regulates mRNA
30 end-processing, but Gtpbp2 appears to lack that function (Woo
et al., 2011). Here we show that Gtpbp2 interacts directly with
Smad1, can potentiate BMP signaling and activate BMP target
genes, is required for embryonic responses to BMP signaling, and
is essential for normal ventral–posterior mesodermal patterning in
Xenopus laevis embryos.
Materials and methods
cDNA isolation and constructs
A partial clone corresponding to the C-terminus of Gtpbp2 was
retrieved from a yeast two-hybrid screen done with a Xenopus
oocyte cDNA library (Clontech) using Smad1 as bait (Zhu et al.,
1999). Full length EST for gtpbp2 (DT061674) was obtained from
Resgen Inc. For mRNA synthesis and expression in cultured cells,
Gtpbp2 isoforms including one with mismatches at morpholino
binding sites were ampliﬁed by PCR and subcloned into pCS2-HA
or pCS2. The HindIII-XbaI fragment of pCS2-HA for each construct
was then subcloned into pCDNA3.1NotI. Final constructs were
linearized with NotI, and mRNAs were made using an mMESSAGE
mMACHINE T7 Kit (Ambion). Deletion constructs for Gtpbp2ΔN
and Gtpbp2ΔC were made by PCR from parent vector; 3xHA-
Gtpbp2-pcDNA3.1NotI. N0 Cherry tagged versions of Gtpbp2 iso-
forms were made by cloning Cherry sequence into XhoI sites
of 3xHA-Gtpbp2 parent vectors, thereby replacing the 3xHA tag.
C0-ﬂag-Xenopus Smad1 was cloned by PCR addition of a C-terminal
ﬂag tag into pCS2. Flag–MH1 and Flag–MH2 were derived from
this parental construct by PCR deletion of excluded sequences. All
PCRs were performed using Platinum Pfx polymerase (Invitrogen)
with low cycle number (o18 cycles). Xenopus Flag-Smad1, and
ﬂag-Smad4 were previously described. (Thomsen, 1996; Zhu et al.,
1999).
Morpholino design and injection
Xenopus laevis embryos were collected and microinjected as
described previously (Alexandrova and Thomsen, 2006). Morpholino
oligonucleotides (MOs) were supplied by GeneTools Inc., as follows,
M2: TCCCCCTGACTGGCACGGAATGCCC, M1: CGCGGCTCCATCC-
CACCGGCCCTG, 5mis-to-M1: CcCGGgTCCATgCCACCcGCCgTG. X. laevis
is an allotetroploid organism in which most of the genes, if not all, are
coded from duplicated copies (Uno et al., 2013). Morpholinos were
designed to target both copies of Gtpbp2.
Immunoprecipitation and western blots
Full-length and deletion constructs of HA tagged Gtpbp2 iso-
form b were co-transfected with full length Flag-tagged Smad1, or
deletion constructs of Flag–Smad1, to Hek293T cells using trans-
fection reagent Fugene6 (Roche). Cells were lysed 24 h after
transfection with PBS containing 1% Triton X-100, 2 mM EDTA,
1 mM Na3VO4 and complete protease inhibitors (Roche). Immu-
nocomplexes were precipitated and washed according to the Flag-
M2 Beads protocol (Sigma). Anti-HA-HRP (Roche) (1:500) and
anti-Flag M2 (Sigma) (1:2000) followed by anti-mouse-HRP anti-
body (Sigma) (1:5000) were used to detect HA–Gtpbp2 forms and
Flag–Smad1 constructs, respectively. A Flag-GFP construct was
used as a balancer in DNA transfections into cultured cells.
in situ hybridization and developmental RT-PCR
A fragment corresponding to positions 609–1510 of Xenopus
gtpbp2 reference sequence NM_001099909 was PCR ampliﬁed,
and cloned into pGEMT-Easy (Promega). The gtpbp2 RNA in situ
probe was made from the pGEMT-Easy construct linearized with
ApaI, transcribed with SP6 RNA polymerase, and labeled with
digoxygenin-UTP (Roche). Whole mount in situ RNA hybridization
was performed as described (Harland, 1991). in situ hybridization
on sections was performed as described (Ciau-Uitz et al., 2000).
Real-time quantitative PCR was performed with a LightCycler 480
System (Roche) to determine the developmental expression of
gtpbp2, using primer pair: GTACGCTCTGGAGCCTGATG and
TGTCTGCACCGACCTTCTCT. Digoxygenin (dig) labeled in situ
probes for analysis of morphant embryos were made as described
previously (Alexandrova and Thomsen, 2006).
Xenopus animal cap assays and quantitative RT-PCR
Synthetic mRNAs or MOs were injected into the animal pole of
2-cell stage embryos at doses indicated in the ﬁgures and text. The
total amount of synthetic mRNA injected was held constant by
balancing with GFP mRNA. Animal caps were excised at blastula
stage 8, cultured in 0.5 MMR, and harvested at Nieuwkoop and
Faber stage 11 (mid-gastrula) or 18 (late neurula). Ten animal caps
per each treatment were pooled and total RNA was extracted as
described (Alexandrova and Thomsen, 2006), followed by cDNA
synthesis with Superscript II Reverse Transcriptase (Invitrogen)
using oligo-d(T)16–20 primers (Invitrogen). Real-time quantitative
PCR (qPCR) was performed with the LightCycler 480 (Roche), using
primer sequences and conditions as described (Xanthos et al.,
2002; 〈http://www.hhmi.ucla.edu/derobertis/〉). Marker gene
expression levels in cultured animal cap explants were normalized
to an endogenous control gene (ornithine decarboxylase, ODC), and
then plotted as a percentage of the level of endogenous gene
expression in one embryo (set as 100%).
Luciferase reporter gene assay
Reporter assays were done by injecting 100 ng Vent2-Luc
reporter (Hata et al., 1998) together with 50 ng TK-RL reporter as
internal control to normalize the reporter activity, and 20–40 ng of
M1 or 40 ng 5-base mismatched (5mis), morpholinos designed
against Gtpbp2. Animal caps were explanted at stage 8 and
harvested at stage 11. Ten animal caps or embryos per each
treatment were pooled and extracts were prepared and analyzed
using a Dual-Glo Luciferase Assay System (Promega).
Immunoﬂourescence and imaging:
mCherry-tagged gtpbp2a (2 ng) and membrane localized GFP
(5 pg) synthetic mRNA were co-injected into the animal pole of 2-
cell embryos, and then gently ﬁxed at gastrula stage 11 in 1%
paraformaldehyde in PBS for 15 min, washed 3 times in PBS, and
then costained with 2 mg/ml 4,6-diamino-2-phenylindole (DAPI).
Embryos were then imaged using a 10 objective on a Zeiss
ﬂuorescence microscope (Motorized Axio Imager Z1) with Apo-
Tome attachment.
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Results
Identiﬁcation of Xenopus Gtpbp2
We sought to identify new regulators of Smad signaling by
performing a yeast two-hybrid screen using Xenopus Smad1 as bait
to probe an oocyte cDNA library. One of the cDNAs we retrieved
encodes a predicted C-terminal, 144 amino acid fragment with
signiﬁcant homology to human and mouse Gtpbp2 (Fig. 1A), a
large GTPase that, together with a homolog named Gtpbp1, deﬁne
a small yet distinct family of GTPases with closest homology to
translation elongation factor eEf1a. Gtpbp1/2 orthologs are con-
served throughout the metazoa (Kudo et al., 2000; Watanabe et
al., 2000) and feature three conserved domains: an N-terminal
portion harboring a GTP-binding/GTPase domain with sequence
conservation that places these GTPases (and eEf1a) within the
greater ras superfamily. This domain binds Guanine nucleotides,
and in eEf1a and Gtpbp1 it has been shown to possess GTPase
activity (Riis et al., 1990; Woo et al., 2011). The C-terminal halves of
Gtpbp1 and 2 feature two conserved sequence blocks, referred to
as EF-Tu (or Gtpbp) domains II and III (Fig. 1A), and while the
function of those domains in Gtpbp1/2 are not known, in eEf1a
and EF-Tu those regions bind to GTP/GDP and aminoacyl-tRNAs
and facilitate delivery of charged tRNAs to actively translating
ribosomes (Sasikumar et al., 2012).
The human gtpbp2 locus codes for two isoforms of Gtpbp2
protein (UniProtKB Q9BX10.1): a 602 amino acid (aa) “long form”
Gtpbp2a (NP_061969.3), and a shorter 514 aa variant, Gtpbp2b
(NP_001273145.1). These human isoforms share a common open
reading frame (ORF), but isoform b transcripts are initiated within
the ORF of isoform a, resulting in use of an alternative start codon
in isoform b and a lack of the ﬁrst 88 amino acids found in isoform
a (Figs. 1A and S1). This is consistent with original cloning reports
indicating different protein sizes for human and mouse Gtpbp2
(Watanabe et al., 2000; Kudo et al., 2000). A search for corresponding
transcripts in Xenopus laevis and Xenopus tropicalis EST databases
yielded multiple cDNAs that encode the Gtpbp2a isoform, but just
one X. laevis cDNA (genbank ID BI449029) that would correspond to
the mammalian gtpbp2b transcript and protein. While we cannot
rule out the possibility that this Xenopus transcript is a partial cDNA,
we used it in functional tests (below) since it encodes the equivalent
of the mammalian Gtpbp2b isoform and was the ﬁrst cDNA we
isolated for expression analysis and functional testing. This clone also
showed more robust protein expression than that of the full-length
gtpbp2a when the mRNAs were injected into embryos (below and
Fig. 6). The X. laevis long form is 81% identical to human Gtpbp2a and
since the mRNA encoding this protein appears to be the predominant
form expressed in early X. laevis embryos, we refer to this as Gtpbp2
henceforth, unless stated otherwise.
Gtpbp2 interacts with Smad1
We isolated Gtpbp2 as an interactor with Smad1 in a yeast
2-hybrid screen; hence to validate this interaction, we performed
co-immunoprecipitation (co-IP) assays in mammalian cells by
cotransfecting HA-tagged Gtpbp2 together with Flag-tagged
Smad1 into human Hek293T cells. Fig. 1B shows that HA–Gtpbp2
co-immunoprecipitates with the ﬂag-tagged Smad1. To conﬁrm
whether Gtpbp2 interacts directly with Smad1, we incubated a
puriﬁed GST–Smad1 fusion protein together with in vitro synthe-
sized and 35S-labeled proteins for Gtpbp2, Gtpbp1, GFP or Smurf1
(as a positive control) and found that both Smurf1 and Gtpbp2
bind to Smad1, while Gtpbp1 does not (Fig. 1C). These results show
that the interaction between Smad1 and Gtpbp2 is direct, and also
indicate that Smad1 interacts selectively with Gtpbp2 but not its
closest homolog Gtpbp1 (also veriﬁed in a separate study of
Gtpbp1; D. Ki and W. Gillis, unpublished observations).
Fig. 1. Gtpbp2 interacts with Smad proteins. (A) Schematic representation of Gtpbp2 and its conserved domains. Partial-length proteins isolated by yeast two-hybrid (Y2H)
or constructed for interaction assays (ΔC and ΔN) are delineated by horizontal lines. Symbols A and B indicate the position of ATG start codons in the corresponding two
isoforms of human Gtpbp2 protein. (B) Flag–Smad1 construct was co-expressed with HA–Gtpbp2B in Hek293T cells, lysed, immunoprecipitated (IP) with Flag–agarose beads,
and analyzed by western blot (WB) using α-HA-HRP and α-ﬂag M2 antibodies. Lower panel shows Gtpbp2b levels in total cell lysates (TCL); top two panels show
co-immunoprecipitated proteins. (C) Xenopus Gtpbp1, Gtpbp2 and Smurf1, or GFP was individually translated in vitro in rabbit reticulocyte lysates, and labeled with
35S-Methionine. GST and GST–Smad1 proteins were expressed in and puriﬁed from E. coli. Puriﬁed GST-tagged proteins were incubated with each in vitro translated protein
and pulled down by GST beads. Gtpbp2 interacts with GST–Smad1 in vitro whereas Gtpbp1 does not. Xenopus Smurf1 was used as a positive control and GFP as a negative
control. (D) Flag–Smad1, Flag–MH1 domain, and Flag–MH2 domain constructs (all Xenopus) were co-expressed with HA–Gtpbp2b and analyzed as in panel (B).
(E) HA-tagged Gtpbp2b (full-length), ΔN-Gtpbp2b and ΔC-Gtpbp2b were co-expressed with Flag-tagged Xenopus Smad1 in Hek293T cells and analyzed by IP as in panel (B).
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To further characterize how Gtpbp2 and Smad proteins inter-
act, we deﬁned the interacting domains of Gtpbp2 and Smad1 by
co-immunoprecipitation (co-IP) from COS cells. The predicted
functional regions of Gtpbp2 include the GTP-binding/GTPase
domain encompassing most of the N-terminal half of the protein,
and the EF-Tu_II (GTPBP_II) and EF-Tu_III (GTPBP_III) domains in
the C-terminal half (Fig. 1A). We generated expression constructs
for N- and C-terminal domains of Gtpbp2 as well as MH1 and MH2
domains of Smad1. Results in Fig. 1D demonstrate that the Smad1
MH1 domain interacts with Gtpbp2 much more robustly than the
MH2 domain. In the converse direction, full-length Smad1 was
able to form a complex with Gtpbp2 lacking the GTPase domain
(ΔNGtpbp2), but not Gtpbp2 lacking domains II and III (ΔC Gtpbp2;
Fig. 1E). These results demonstrate that the putative effector domain
of Gtpbp2 interacts with the MH1 domain of Smad1. These ﬁndings
provide a foundation for future detailed structure–function and
mechanistic studies of Gtpbp2–Smad interactions and support a
role for Gtpbp2 in BMP signaling, investigated below.
Expression proﬁle of Gtpbp2 in Xenopus embryos
To assess the roles of Gtpbp2 in developmental processes, we
ﬁrst determined the temporal and spatial expression of gtpbp2
mRNA in developing Xenopus embryos, by in situ hybridization on
whole and histologically-sectioned embryos, as well as by real-
time quantitative RT-PCR (qPCR; Figs. 2 and S2). We found gtpbp2
expressed maternally (egg, cleaving blastula) at levels that were
nearly the maximum observed among all stages measured
(Figs. 2A and S2). The high level of maternal transcripts persisted
into early gastrulation (stage 10) but rapidly decreased by mid-late
gastrulation, stages 11 and 12. Gtpbp2 expressionwas the lowest in
early to mid-neurulae, but transcript levels gradually increased
toward the end of neurulation and in early tadpoles undergoing
organogenesis (Figs. 2D and S2). The maternal transcripts were
found localized to the animal pole of egg and cleavage stage
blastula embryos (Figs. 2A and S2), and at the onset of gastrulation
gtpbp2 transcripts were detected primarily in the mesoderm and
inner cell layer of the ectoderm (Fig. 2B). Although transcript levels
were at their lowest in neurula stages, they were slightly enriched
in the neural folds (Fig. S2). At tailbud and swimming tadpole
stages, gtpbp2 transcripts were expressed prominently in the
ventral blood island, somites, brain and eye (Figs. 2C and S2).
These tadpole expression patterns are congruent with the expres-
sion of adult mouse gtpbp2 transcripts, which were found in the
brain, skeletal muscle and blood (Kudo et al., 2000). In conclusion,
Xenopus gtpbp2 is expressed as a maternal mRNA in the egg, is
zygotically expressed early during gastrulation in the ectoderm
and mesoderm, and later becomes expressed in speciﬁc tissues
during organogenesis in the early tadpole.
Gtpbp2 is required for responses to BMP signaling
To determine whether Gtpbp2 provides any essential functions
in BMP/Smad signaling and in Xenopus development, we designed
translation-blocking antisense morpholino oligonucleotides (MOs)
and implemented them in gene knockdown experiments. Two
translation blocking morpholinos targeted the predicted initiation
codon of Xenopus gtpbp2, corresponding to the AUG of the human
gtpbp2a isoform (Fig. S1B). Gtpbp2 morpholino M1 overlaps this
AUG, and a non-overlapping morpholino M2 is positioned just
upstream of M1 (Fig. 3A). We veriﬁed that these morpholinos
inhibit translation from a reporter mRNA construct consisting of
the gtpbp2a ORF fused to a C-terminal myc tag. When mRNA and
MO were coinjected into X. laevis embryos, the gtpbp2 M1 and M2
morpholinos each blocked expression of this reporter construct
while a control morpholino (5mis), which has 5 mismatches to M1
morpholino binding site, did not (Fig. 3A).
We isolated Gtpbp2 as a Smad1 interacting protein, and
transcripts of both Gtpbp2 (Fig. 1) and Smad1 (Thomsen, 1996)
are expressed in the ectodermal germ layer, or animal cap region,
of blastula and gastrula stage embryos. Animal cap tissue is
pluripotent and can be induced to form different lineages,
depending on the dose and type of growth factor applied (Green
et al., 1992; Asashima et al., 2009); hence animal cap explant
culture has long been used as a simple and effective system to
probe activities of natural and candidate induction signals and
downstream pathway components. Thus, the animal cap is an
appropriate, natural tissue in which to ask whether Gtpbp2 is
required for endogenous or ectopic BMP signaling in a reductive
manner similar to that of mammalian cultured cell lines.
Fig. 2. Temporal and tissue speciﬁc expression of Gtpbp2 during Xenopus laevis development. (A) Maternal gtpbp2 transcripts were detected primarily in the animal pole at
blastula stages (in sectioned stage 7 embryos). (B) At the onset of gastrulation (stage 10) gtpbp2 is expressed in the inner layer of ectoderm and mesoderm. Arrow shows
dorsal blastopore lip. (C) At swimming tadpole stage (stage 35) gtpbp2 is strongly expressed in the somites, as well as in the brain, branchial arches, and ventral blood islands
(VBI). Arrow shows VBI-speciﬁc expression of gtpbp2. (D) Semi-quantitative RT-PCR showing gtpbp2 levels across stages. The gtpbp2 signal signiﬁcantly diminishes as
gastrulation progresses, but is re-expressed at tadpole stages.
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To determine whether Gtpbp2 is required for response to
ectopic BMP signaling, two cell stage embryos were injected into
the animal pole with 500 pg of bmp4 mRNA, together with either
control or Gtpbp2 morpholinos (M1 or M2) and animal caps were
explanted at midblastula stages 7 and 8, cultured and harvested
when control embryos reached stage 11. Coinjection of control
morpholino and bmp4 mRNA into caps induced several ventral
mesodermal genes (ventx1.1, wnt8a, and evx1) that are known
targets of BMP signaling. However, caps coinjected with bmp4 and
Gtpbp2 M1 or M2 morpholinos showed a severely weakened
induction of these BMP4 targets (Fig. 3B and C). These effects of
Gtpbp2 knockdown in animal caps are speciﬁc because reduced
response to BMP4, caused by mopholino M1, can be reversed by
injection of a gtpbp2 mRNA harboring a mismatched morpholino
binding target site (Fig. 3C).
Animal cap tissue has a low level of endogenous BMP signaling
(Wilson et al., 1997; Kuroda et al., 2005) which allowed us to address
whether Gtpbp2 is required for endogenous BMP signaling in animal
cap explants using an alternative, luciferase reporter assay employing
a vent2 promoter, a direct target of BMP signaling (Henningfeld et al.,
2000). Indeed, Gtpbp2 morpholino co-injected into caps along with
the reporter plasmid reduced activation of the vent2-Luc reporter by
about 50% (Fig. 3D). When cultured to neurula stages animal caps
differentiate into epidermis, an outcome that can be altered to
cement gland and neural fates upon inhibition of BMP signaling,
whereby intermediate levels of BMP signaling will lead to induction
of cement gland genes, and in the absence of BMP signaling the cap
tissue differentiates into neural progenitors (Wilson et al., 1997).
Gtpbp2 morphant animal caps expressed decreased levels of the
epidermal marker, cytokeratin (xk81a1), when cultured to early
neurula (stage 15), consistent with a decrease in BMP signaling.
However, Gtpbp2 morphant caps showed no induction of cement
gland (ag1), or neural markers (sox2, and ncam1) (Fig. S3C). Thus,
although Gtpbp2 is required for optimal endogenous, as well as
ectopic/elevated, BMP signaling in the Xenopus ectoderm, it does not
appear to be required for BMP signaling that represses neural fate.
Fig. 3. Gtpbp2 is required for BMP signaling in Xenopus animal cap tissue culture. (A) Two non-overlapping morpholinos are designed against the start site of gtpbp2 mRNA
(M1 and M2), along with a control morpholino which has 5 mismatches to M1 binding site. Western blot shows Gtpbp2 morpholinos, M1 and M2, block translation of a
C-terminally myc-tagged partial Gtpbp2 reporter construct injected into X. laevis embryos whereas a 5-mismatch to M1 control morpholino does not interfere with the
expression of this reporter construct. A gtpbp2–myc mRNA (1 ng) harboring the 50UTR and ﬁrst few amino acids preceding the conserved domains of Gtpbp2 was coinjected
with gfp mRNA (1 ng) and the morpholinos. Gtpbp2–myc protein levels were assayed by western blotting using anti-myc and anti-GFP antibodies, in embryo lysates
harvested at mid-gastrulation (stage 11). (B) Loss of Gtpbp2 inhibited BMP signaling. Embryos were injected at two-cell stage with 500 pg bmp4 mRNA, and 20 ng M1, or
40 ng M2, or 40 ng 5 mismatched-to-M1 morpholino (mis). Animal cap tissue was dissected at Stage 8, and cultured to Stage 11. BMP responsive genes ventx1.1 (vent1),
wnt8a (wnt8), evx1 (xhox3) were assayed by quantitative RT-PCR (qPCR). (C) Co-injection of 100–400 ng of a Gtpbp2 mRNA without morpholino target sites along with M1
morpholino restores BMP signaling in cultured animal cap explants. BMP signaling was assayed by the response of BMP target genes, by qPCR. (D) BMP signaling was assayed
with a BMP/Smad1-responsive vent2:luciferase reporter in animal caps. This reporter is signiﬁcantly expressed when injected into animal caps with control morpholino, but
including 20 or 40 ng of Gtpbp2 morpholino M1 reduces Vent2–luciferase reporter activity to about half that of the control level (standard error indicated). Endogenous BMP
response genes: evx (Xhox3), ventx1.1 (vent1) and wnt8a (wnt8). Assays in (B, C) performed on two or more biological replicates.
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Gtpbp2 is required for ventral mesoderm patterning
Next, we proceeded with morpholino knockdown experiments in
Xenopus embryos, to evaluate phenotypes and assess the potential
contribution of putative Gtpbp2 isoforms to early development.
Following bilateral injection of MOs at the two-cell stage, abnorm-
alities in Gtpbp2 morphants were ﬁrst observable in the late gastrula
as a delay in blastopore closure (not shown). This suggested that
Fig. 4. Gtpbp2 is required for embryonic ventrolateral mesoderm patterning. (A) Gtpbp2 is required for posterior tissue development. Diagram depicts the way 4-cell X.
laevis embryos were injected. Colored ﬁgure is shown to illustrate how dorsal (D) and ventrally-fated blastomeres (V) are identiﬁed and injected. Dorsal is the lighter
pigmented half. Grayscale ﬁgure is the lateral view of the embryo. Embryos were injected with 30 ng Gtpbp2 morpholino into the two ventral blastomeres at the 4-cell stage,
placed in the ventral marginal zone (VMZ) and cultured to stage 35. Loss of Gtpbp2 leads to the complete loss of tail and posterior tissues. (B) Morpholino knockdown of
Gtpbp2 results in a severe reduction of post (xpo), wnt8, and myod1 (myf3) expression. Vent1 expression domain is more restricted to ventral tissues compared to controls.
Embryos were injected with 30 ng Gtpbp2 morpholino at 4 cell stage targeting the VMZ; the future posterior ventral tissues. (C) Gtpbp2 is not required for mesendodermal
induction. Sox17a, mixer, and mix1 expressions are not affected. Embryos were injected bilaterally with 40 ng Gtpbp2 morpholino at the 2-cell stage. Three independent sets
of at least 20 embryos were analyzed in B and C, resulting in similar effects on marker gene expression.
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early germ layer speciﬁcation, patterning or morphogenetic pro-
cesses, particularly those affecting the mesoderm, might be disturbed
in the morphants. Since Gtpbp2 is required for BMP signaling, we
expected that interfering with Gtpbp2 protein expression with
morpholinos might cause body patterning defects. We observed that
injection of M1 into the ventral–posterior marginal zone (VMZ) of
4-cell blastulae inhibited formation of the tail, posterior trunk and
somites (Fig. 4A), which conﬁrms a requirement for Gtpbp2 in the
formation of ventral–posterior tissues. The loss of posterior struc-
tures in Gtpbp2 morphants could be partially rescued by co-injection
of a gtpbp2a rescue mRNA (with 5 synonymous mismatches to the
morpholino sequence; Fig. S3).
To further investigate the ventral–posterior defects in Gtpbp2
morphants, we scored expression of region-speciﬁc patterning
markers by whole-mount in situ hybridization (WISH) and found
abnormal expression of several key genes that inﬂuence meso-
derm development in the gastrula. VMZ targeting of the Gtpbp2
morpholino, as above (Fig. 4A), resulted in complete loss of the
ventral–posterior marker genes post (xpo), wnt8a, and myod1
(myf3), and also inhibited lateral expression of ventx1.1, restricting
it to the ventral-most region of the embryo (Fig. 4B). In contrast
the expression patterns of the mesendodermal marker genes,
mix.2 and mixer, and the endoderm-speciﬁc marker gene sox17a
were not appreciably affected by Gtpbp2 knockdown in embryos
bilaterally injected at the 2-cell stage (Fig. 4C).
To substantiate the effects we observed on molecular markers
by the WISH analysis, above (Fig. 4), and to more accurately
determine the relative expression levels of patterning genes in
Gtpbp2 morphants, we performed qPCR on embryos injected
bilaterally at the 2-cell stage with 40 ng of control or Gtpbp2
MO1 (Fig. 5). In agreement with the WISH results above, we
detected signiﬁcantly reduced expression of ventral–posterior
markers, post (xpo), and evx1 (xhox3) in Gtpbp2 MO injected
embryos at mid-gastrulation, stage 11 (Fig. 5A). Curiously while
vent1 expression appears restricted to the ventral-most regions in
the embryos in Gtpbp2 MO injected embryos (Fig. 4B), and is
reduced in animal cap assays, we did not observe a consistent
effect on expression levels of vent2 or vent1 by qPCR, either early
(stage 10) or at mid-gastrula (stage 11) (Fig. 5A and B). Consistent
with WISH results, expression of pan-endodermal marker sox17a
remained unchanged in early to mid-gastrula embryos stages 10
and 11 (data not shown). These results demonstrate that Gtpbp2 is
required for normal mesodermal ventral–posterior patterning.
Moreover, the decreased expression of BMP-controlled, ventral–
posterior genes wnt8a, post, and evx1 supports our results with
animal cap assays that Gtpbp2 is required for aspects of BMP
signaling in the Xenopus embryo.
Gtpbp2 overexpression induces mesodermal markers in animal cap
explants
Our loss of function experiments support the hypothesis that
Gtpbp2 is required for BMP signaling, but to gain more insight
into the activities of Gtpbp2, we analyzed the subcellular locali-
zation and effects on gene expression of overexpressed Xenopus
equivalents of the human Gtpbp2a (long) and Gtpbp2b (short)
variant proteins in Xenopus animal caps (Fig. 6). These variants
are generated by alternative transcript initiation and ﬁrst exon
splicing (Fig. S1), but it is unclear whether the Xenopus genome
encodes such short and long Gtpbp2 isoforms. However, as noted
above, we obtained one X. laevis cDNA that fortuitously encodes
the equivalent of Gtpbp2b, as well one encoding Gtpbp2a, which
corresponds to all other X. laevis gtpbp2 transcripts annotated in
the genbank database. We constructed HA epitope and mCherry
tagged forms of these Xenopus gtpbp2 variants, and analyzed
where the proteins are located when expressed in Xenopus
animal cap ectodermal cells and human cultured (COS) cells.
We found that the HA- or mCherry-tagged Gtpbp2a/b isoforms
can exhibit both nuclear and cytoplasmic localization, with
higher expression levels driving nuclear localization (Figs. 6A,
S5D,E and S6).
With animal cap assays we scored marker gene induction by
the Gtpbp2a/b isoforms, using conventional gel-based RT-PCR
and qPCR, and we found that Gtpbp2b readily induced the
ventro-posterior mesodermal genes vent1.2, evx1, and wnt8a
(Fig. 6C and D), while Gtpbp2a induced weak to modest expres-
sion of these genes. Levels of gene activation by the Gtpbp2
variants were proportional to mRNA dose and, on an mRNA basis,
Gtpbp2a consistently appeared to be less potent than Gtpbp2b.
To investigate the basis of this difference, we examined the
relative expression levels of the two proteins by western blot,
and found that Gtbpb2b accumulated to much higher steady state
levels than Gtpbp2a, when the same amount of mRNA was
injected into embryos (Fig. 6D). HA–Gtpbp2b protein levels
always exceeded those of HA–Gtpbp2a, even when four times
as much HA–gtpbp2a mRNA was injected into sibling batches of
embryos. The reason for these differences in protein levels (e.g.
translation efﬁciency, protein stability) is unknown. However,
when the protein levels are normalized, Gtpbp2a still appears to
be less active than Gtpbp2b in animal cap gene activation assays.
For example, injecting either 1.0 or 4.0 ng of HA–gtpbp2a mRNA
produced about the same amount of protein as 0.2 or 1.0 ng of
HA–gtpbp2b, respectively, yet gene induction by Gtpbp2b was
much greater than that by Gtpbp2a at either protein level. The
molecular basis for these activity differences is unknown, but it
may reﬂect differences between the N-termini of the a and b
isoforms.
Fig. 5. Gtpbp2 is required for embryonic ventrolateral mesoderm patterning gene
expression. Quantitative RT-PCR (qPCR) analysis of gene expression in control and
Gtpbp2 morphant embryos. (A) Early gastrulation (stage 10.25) and (B) mid-
gastrulation (stage 11), embryos have severely decreased expression levels of ventral
lateral genes post (xpo) and evx1 (xhox3), but mild or no change in vent1 or vent2
expression. Ventral genes; ventx1.1 (vent1), wnt8a (wnt8), evx1 (xhox3) were assayed
by qPCR. Relative expression is normalized to control morpholino-injected embryos.
Black bars indicate standard error from triplicate biological replicates.
A. Kirmizitas et al. / Developmental Biology 392 (2014) 358–367364
Discussion
In this study, we have performed some of the ﬁrst functional
analyses of a rather enigmatic large GTPase, Gtpbp2. We have
identiﬁed Gtpbp2 as a novel binding partner to Smad1, and have
shown that the Smad1 MH1 domain interacts with the Gtpbp2 C-
terminal effector region. Both loss and gain of function analyses show
that Gtpbp2 is required for complete induction of BMP gene targets
in ligand-injected animal caps. Furthermore, we found that depletion
of Gtpbp2 protein in ventral tissues resulted in both a reduction in
BMP signaling targets and defects in ventral/posterior structures,
consistent with a reduction in Smad1 activity, and consistent with
expression of the gtpbp2 gene in the nascent ectoderm and meso-
derm. Overexpression of Gtpbp2 can also induce endogenous BMP
response genes and other mesodermal marker genes in Xenopus
animal cap explants. Our ﬁndings point to a role for Gtpbp2 in BMP
signaling, although the exact mechanism is not known.
BMP signaling is required for patterning of the ventral–posterior
mesendoderm, acting together with, but upstream of Wnt signals
(Kimelman, 2006; Wills et al., 2008; Itasaki and Hoppler, 2010). BMP/
Smad1 signaling also counteracts an intrinsic neural differentiation
program in the nascent ectoderm (Wilson et al., 1997). In Xenopus, as
in other vertebrates and bilaterians in general, BMP signaling
provides information to pattern the early embryo along the dorsal–
ventral body axis, and concomitantly specify posterior mesodermal
fates (Munoz-Sanjuán and H-Brivanlou, 2001; Lane et al., 2004;
Nishimatsu and Thomsen, 1998; Szeto and Kimelman, 2004; Zakin
et al., 2005). In our present study, we found that morpholino
knockdown of Gtpbp2 truncates posterior embryonic structures in
the Xenopus embryo, and severely reduces the expression of early
ventral–posterior mesodermal marker genes, speciﬁcally post, wnt8a,
myod1, and evx1 (Figs. 4 and 5), consistent with a role in ventral–
posterior patterning through BMP/Smad1 signaling.
Our initial results showing that Gtpbp2 morphant embryos have
signiﬁcantly decreased BMP target gene expression and posterior
morphological defects were conﬁrmed in tests on animal caps, in
which we observed that knockdown of Gtpbp2 blocked responses to
endogenous BMP ligands or exogenous (overexpressed) BMP4. Thus,
Gtpbp2 is required for response to BMP ligand. However, Gtpbp2
morphant caps do not express neural markers that would be
expected from a complete inhibition of BMP signaling. Additionally,
while Gtpbp2 appears to be required for BMP related induction of
vent1 in animal caps, vent1 or vent2 showed little or no decrease in
whole embryos injected with Gtpbp2 morpholinos. These ﬁndings
lead us to suggest that Gtpbp2 is a potentiating, but not obligate,
factor for BMP signaling responses, although it is quite conceivable
Fig. 6. Gtpbp2 subcellular localization and induction of BMP target genes. (A) mCherry-tagged Xenopus Gtpbp2a mRNA (2 ng), co-injected with a membrane-localized GFP
(mem-GFP) mRNA (10 pg), and costained with DAPI, shows nuclear and cytoplasmic localization in gastrula stage 11 animal cap cells; (i) mCherry–Gtpbp2 signal only, (ii)
merged signals for mCherry–Gtpbp2b, mem-GFP and DAPI. (B) X. laevis Gtpbp2b can induce BMP marker genes evx1, wnt8a, vent2.2 in animal caps. gtpbp2bmRNAwas injected
at increasing doses (0.2 ng, 1 ng, and 4 ng) into the animal pole of two cells stage embryos, animal caps were excised at stage 8, and cultured to stage 11 before gel-based RT-PCR
with primers to indicated genes (otx as positive control for RT and loading). (C) qPCR analysis of the BMP targets vent1.2, wnt8, and evx1 in animal caps injected at the 2 cell stage
with increasing doses of gtpbp2a or gtpbp2b mRNA, excised at the 8 cells stage, and cultured to stage 11. (D) Comparison of accumulation of HA-tagged X. laevis Gtpbp2a versus
Gtpbp2b isoforms in embryos injected with increasing doses of mRNA at the 2- cell stage and lysed at stage 11 for western blotting using an anti-HA antibody.
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(even likely) that small levels of Gtpbp2 protein remain after
morpholino knockdown to perform any essential roles. Assessments
in a true loss-of-function animal or cell line will help addresss such
issues and answer other mechanistic questions. Nevertheless, we
conclude Gtpbp2 is required for posterior mesodermal patterning of
the Xenopus embryo through its role in BMP signaling.
Expression of the gtpbp2 gene suggests that it has an early,
general role in mesodermal and ectodermal patterning, followed by
tissue speciﬁc roles in later development during organogenesis.
There is a signiﬁcant amount of maternal gtpbp2 mRNA localized to
the blastula animal hemisphere, which appears to be augmented by
zygotic gtpbp2 expression in the early mesoderm (Fig. 2). Based on
our functional tests these maternal and early zygotic phases of
Gtpbp2 expression appear to potentiate BMP signals, yet we ﬁnd
no consistent effect of Gtpbp2 knockdown on animal cap responses
to Nodal (supplied as Xnr2, nodal2; results not shown). Potential
roles for Gtpbp2 in other pathways cannot be ruled out, however,
particularly since orthologs exist in non-metazoans that lack some or
all BMP and TGFβ signaling pathways (e.g. fungi, Fig. S4).
As development proceeds past blastula stages, Gtpbp2 expression
falls precipitously at the onset gastrulation, then slowly rises during
neurulation in a pattern that is slightly enriched in neural folds
(Fig. S2). In tailbud through hatching tadpole development, gtpbp2
transcripts are predominantly expressed in the brain, somites, and
ventral blood island all of which are regulated to some degree by
BMP signals. The expression in the blood island is particularly
noteworthy since the VBI is the site of primitive hematopoiesis
under the direction of BMPs (Schmerer and Evans, 2003; Myers and
Krieg, 2013). Gtpbp2 was originally isolated as an interferon induci-
ble gene in monocytes, but its early, essential role in mesodermal
germ layer formation has prevented us from analyzing its potential
role in blood development using morpholino technology.
The precise molecular mechanism by which Gtpbp2 regulates
BMP signaling, or activates BMP response genes when overex-
pressed, is currently unclear; however Gtpbp2 appears to function
downstream of both Smad1 protein stabilization processes and
Smad1 activation via phosphorylation by Bmp Type I receptors. For
instance, we found that embryos overexpressing tagged Gtpbp2,
or injected with Gtpbp2 morpholino, showed no apparent effects
on endogenous levels of total Smad1 protein, or activated
phospho-Smad1 (Fig. S5A). Knockdown of Gtpbp2 also does not
appear to affect the formation of Smad1–Smad4 complexes, as
Gtpbp2 morphants and controls show no difference in the levels
of tagged-Smad1 that co-immunoprecipitates with myc–Smad4
(Fig. S5B). In animal cap assays, Gtpbp2a appears to be less potent
than Gtpbp2b at inducing BMP target genes, when overexpressed.
While the molecular basis of this difference remains to be
determined, this observation could have functional implications
in systems where gtpbp2 transcripts may be differentially spliced
to produce one or the other isoform (particularly in human).
However, in Xenopus embryos, gtpbp2 transcript proﬁles indicate
that Gtpbp2a is the predominantly expressed form, and this
likelihood is supported by our ﬁndings that targeting the ATG
start codon of potential gtpbp2b transcripts with a morpholino
causes no signiﬁcant embryonic phenotype (results not shown).
Subcellular localization experiments indicate that Gtpbp2 has the
potential for cytoplasmic and nuclear functions. We found over-
expressed, tagged Gtpbp2a protein localizing to the nucleus of either
intact or disaggregated Xenopus ectodermal cells at early gastrulation
(Figs. S5C and S6). Consistent with this data, we found overexpressed
Gtpbp2b and Smad1 proteins colocalizing to nuclear foci in COS cells
(Fig. S5E), which may reﬂect a role in the formation of transcriptional
complexes. The localization of Smads to subnuclear foci in similar
speckled patterns has been observed previously (Janknecht et al.,
1998; Yoshida et al., 2000), including activated Smad1/5 and a
transcriptional partner, Runx (Zaidi et al., 2002). Hence, it is possible
that Gtpbp2–Smad1 complexes are engaged in transcriptional activ-
ities in these nuclear foci. However, since we observe that nuclear
localization of GFP–Smad1 is unaffected in Gtpbp2morphant cells (Fig.
S5C), Gtpbp2 does not appear to be required to redirect nuclear
localization of Smad1. Furthermore the subcellular location of endo-
genous Gtpbp2 protein described in the Human Protein Atlas appears
cytoplasmic, but not nuclear, in the tissues examined (Uhlen et al.,
2010). We also ﬁnd that increasing the level of Xenopus Gtpbp2a in
mammalian cells can shift its localization from cytoplasm to nucleus,
but the Xenopus version of human Gtpbp2b readily localizes to the
nucleus (Fig. S5D). The subcellular localization of Gtpbp2 therefore
may depend on dose, isoform type (a versus b) or interacting partner.
These differences in localization might affect differences in the ability
to induce BMP target genes.
Gtpbp2 is part of a superfamily of large GTPases that include
eEf1a (elongation factor 1 alpha). The closest homolog of Gtpbp2,
Gtpbp1, has been shown to target mRNAs and enhance their turn-
over through its interaction with 30 RNA end-processing exosome
complex (Woo et al., 2011). Not only are Gtpbp2 and Gtpbp1 distantly
related to translation elongation factors, but also they have homology
with other proteins that are involved in mRNA turnover, such as
Hbs1 (Tsuboi et al., 2012). Thus, it is conceivable that Gtpbp2 might
function in mRNA turnover as well. However, unlike Gtpbp1, Gtpbp2
does not bind to exosome components, nor does it promote similar
decay of mRNA targets (Woo et al., 2011). Additionally, the ﬁnding
that Gtpbp2 knockdown has an effect on a vent2 reporter, but not
endogenous vent1 or vent2mRNA steady state levels in caps, strongly
suggests that Gtpbp2 promotes Smad1 activity, rather than stability
of Smad1-induced transcripts. Conversely, puriﬁed Gtpbp2, but not
Gtpbp1, interacts with Smad1 in an in vitro binding assay, and
Gtpbp1 does not show similar activity in promoting BMP signaling in
animal caps (data not shown), providing further evidence that
Gtpbp1 and Gtpbp2 do not overlap in function. Indeed the Gtpbp1
and Gtpbp2 paralogs appear to be present in all animals (Fig. S4), and
even in the mold Neurospora crassa, suggesting that these genes
arose from an ancient duplication predating the emergence of
animals, as well as the TGFβ signaling system, and therefore it is
not at all surprising that these would have non-redundant functions
or that Gtpbp2 might have additional cellular functions besides BMP
signaling. Finally embryo-wide or dorsal targeted knockdown of
Gtpbp2 results in a complex phenotype not explained by effects on
BMP or Nodal, indicating that Gtpbp2 likely functions in other
signaling pathways. These phenotypes and associated analyses will
be presented in a separate study (in preparation).
Conclusions
In summary we have discovered that Gtpbp2, a large GTPase of
previously unknown function, is a novel binding partner of Smad1
and is required for BMP signaling in the Xenopus embryo. Gtpbp2
is expressed in the nascent ectoderm and mesoderm, and in major
sites of organogenesis during Xenopus development, and gain and
loss of function analyses show that Gtpbp2 is required for BMP
target gene induction and development of BMP-dependent ven-
tral–posterior body structures. Gtpbp2 appears to operate in BMP
signaling downstream of Smad1 activation and has the potential to
act in nuclear or cytoplasmic compartments.
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